Evidence map›Paper›PMID 41410729›Full record

ReviewJournal of cancer survivorship : research and practice2025

The role of community pharmacists in cancer survivorship care - a scoping review.

Ola K Taleb, Vijayaprakash Suppiah, Nadia Corsini, Alexandra Stokes, Agnes Vitry, David Roder, Kerri Beckmann

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ola K TalebCancer Epidemiology & Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, Australia. ola.taleb@mymail.unisa.edu.au.
Vijayaprakash SuppiahAustralian Centre for Precision Health, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Nadia CorsiniRosemary Bryant AO Research Centre, Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
Alexandra StokesCancer Epidemiology & Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, Australia.
Agnes VitryClinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
David RoderCancer Epidemiology & Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, Australia.
Kerri BeckmannCancer Epidemiology & Population Health Research Group, Allied Health and Human Performance, University of South Australia, Adelaide, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis scoping review aimed to (1) explore the role of community pharmacy-based cancer survivorship care, (2) report any patients' and services' outcomes from community pharmacy care in cancer survivorship care, and (3) identify barriers and facilitators encountered by community pharmacists in providing survivorship support.

methodA search strategy was conducted across Medline (Ovid), Scopus, Embase (Ovid), Cochrane Library and CINAHL, supplemented by grey literature and a reference list screening. Abstract and full text screening was carried out according to the inclusion and exclusion criteria based on the PCC framework (Population, Concept, Context).

resultForty-two articles were included. Studies demonstrated emerging roles for community pharmacists across five key focus areas: (1) medication dispensing and management, (2) lifestyle and supportive care, (3) side effects management, (4) emotional and psychosocial support, and (5) collaboration with other healthcare providers. Current interventions showed positive impacts on patients' quality of life and on the quality of cancer survivorship care provided. Key barriers included a lack of oncology-specific knowledge and training among community pharmacists, their limited access to patient records, a lack of integration into oncology care teams, limited patient awareness of available pharmacist services, and limited resources. The facilitators comprised increased education and training in oncology, greater access to patient records, and better communication among healthcare providers.

conclusionCommunity pharmacists have potential to contribute to cancer survivorship care but face several barriers that need to be addressed. IMPLICATIONS FOR CANCER SURVIVORS: This review highlights the opportunity of community pharmacists to support cancer survivors.

Indexed as

CancerCommunity pharmacistsSurvivorship

Identifiers

PMID41410729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.